Literature DB >> 200333

Human leukemic "null" cell line (NALL-1).

S Hiraki, I Miyoshi, I Kubonishi, Y Matsuda, T Nakayama, H Kishimoto, H Masuji.   

Abstract

A human lymphoblast cell line, NALL-1, was established from the peripheral blood of a patient with acute lymphoblastic leukemia (ALL). NALL-1 cells had neither properties of T and B cells nor Epstein-Barr virus (EBV). Many characteristics of the NALL-1 line were distinct from those of numerous EBV-positive lymphoblastoid cell lines previously reported. NALL-1 cells are considered to have originated from the donor's leukemic cells on the basis of their cytogenetic, morphologic and functional features. The NALL-1 line is the first human leukemic "null" cell line derived from ALL. The significance of this cell line is disscussed.

Entities:  

Mesh:

Year:  1977        PMID: 200333     DOI: 10.1002/1097-0142(197711)40:5<2131::aid-cncr2820400523>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme.

Authors:  N Kamatani; W A Nelson-Rees; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

2.  Gene for human CD59 (likely Ly-6 homologue) is located on the short arm of chromosome 11.

Authors:  U H Forsberg; V Bazil; I Stefanová; J Schröder
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.

Authors:  S F Slovin; D M Frisman; C D Tsoukas; I Royston; S M Baird; S B Wormsley; D A Carson; J H Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

4.  Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines.

Authors:  M O Diaz; S Ziemin; M M Le Beau; P Pitha; S D Smith; R R Chilcote; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

5.  Absence of IgG lymphocytotoxins in untreated Hodgkin's disease (HD) patients.

Authors:  D B Jones; E V Elliott; S V Payne; D H Wright
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

6.  Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody.

Authors:  H Taji; Y Kagami; Y Okada; M Andou; Y Nishi; H Saito; M Seto; Y Morishima
Journal:  Jpn J Cancer Res       Date:  1998-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.